Fluocinonide and Prograf drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fluocinonide (fluocinonide) and Prograf (tacrolimus). Common drug interactions include death among females and oedema peripheral among males.

The phase IV clinical study analyzes what interactions people have when they take Fluocinonide and Prograf. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Fluocinonide?

Fluocinonide has active ingredients of fluocinonide. It is often used in eczema. eHealthMe is studying from 6,385 Fluocinonide users. Check the latest studies of Fluocinonide.

What is Prograf?

Prograf has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 42,230 Prograf users. Check the latest studies of Prograf.

On Jul, 11, 2026

25 people who take Fluocinonide and Prograf together, and have interactions are studied.

Fluocinonide and Prograf drug interactions.

What are the common drug interactions of Fluocinonide and Prograf, by gender? *:

female:

Death
Blood phosphorus increased
Nasopharyngitis (inflammation of the nasopharynx)
Pyelonephritis (inflammation of kidney caused by bacteria)
Urinary tract infection
Diarrhoea
Pain

male:

Oedema peripheral (superficial swelling)
Diarrhoea
Leukocytosis (increased white blood cells)
Pneumonia
Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
Depression
Erythema (redness of the skin)
Gastritis (inflammation of stomach)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Headache (pain in head)

What are the common drug interactions of Fluocinonide and Prograf, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Malignant neoplasm progression (cancer tumour came back)
Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin)

50-59:

Immunosuppression
Injury
Laboratory test abnormal
Limb injury
Lung nodule (solid, raised areas in lung)
Major depressive disorder (a condition characterized by a long-lasting depressed mood or marked loss of interest or pleasure)
Malignant melanoma (skin cancer rises from melancytes)
Medical device complication
Muscle twitching
Obesity (having too much body fat)

60+:

Purpura (purplish discoloration of the skin)
Rash pruritic (redness with itching)
Blood phosphorus increased
Death
Nasopharyngitis (inflammation of the nasopharynx)
Oedema peripheral (superficial swelling)
Pyelonephritis (inflammation of kidney caused by bacteria)
Urinary tract infection
Pain
Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 6 people, 24.00%
Pain: 5 people, 20.00%
Nausea (feeling of having an urge to vomit): 5 people, 20.00%
Itching: 5 people, 20.00%
Cough: 5 people, 20.00%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 8.00%
Indigestion: 2 people, 8.00%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 8.00%
Blood Iron Decreased: 2 people, 8.00%
Acute Myeloid Leukaemia (In Remission): 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Fluocinonide and Prograf?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously